Product Images Steglatro
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Steglatro NDC 50090-6183 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl500906183
This is a description of medication called STEGLATRO GT with an NDC code of 50090-6183-0. It contains the active ingredient ERTUGLIFLOZIN (15 mg). It is produced by B3 Hed cation Solutions LLC and has been assigned product number 7207-0. STEGLATRO GT comes in a bottle of 90 tablets and each tablet comprises 19.43 MO ERTUGLIFLOZIN and L PYROOLUTAMIC ACID. The recommended storage temperature is between 68 and 77 degrees Fahrenheit, in a dry and moisture-free place. As per the label, it is distributed by A-S Medication Solutions, Libertyville, IL 60048. The recommended dosage instructions for STEGLATRO GT are present in the package insert.*
Chemical Structure - steglatro 01
Figure 1 - steglatro 02
Stagiptin, Metiormin, and Imepide are medications given as a single dose of 100mg, 1000mg, and 1mg, respectively. There is also reference to Simvastatin at a single dose, but the exact dose is not available due to incomplete . Ritampin is taken once daily at a dose of 600mg. The geometric mean ratio (90% CI) of different medication combinations are shown in a table, as a reference to their relative efficacy. However, the exact details are not entirely clear due to errors.*
Figure 2 - steglatro 03
This appears to be a table with different medications and their doses. The medications are Stagitin, Metformin, Gumepicide, and Simiastatn. There is some information about the administration of Simiastatn with another medication. There is also a row with some numbers and a heading "Geometric mean ratio". It is unclear what this means without more context. Finally, there is a sentence at the bottom mentioning a single dose of Al ertuglflozin.*
Figure 3 - steglatro 04
The text seems to be a table of numerical data for a medical study evaluating the change in HbA1c levels (a blood sugar marker) of patients taking placebo or different doses of a drug called Ertuglifiozin over a certain period of time. Baseline values are listed on the left and there are mean change values in the middle for each group. However, there is not enough information to interpret the data fully without the context or further explanation.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.